Mold Toxicity and Lyme Disease Mold illness causes many of the same symptoms as Lyme disease
Tyrosinase is a substance that stops the process of melanin
Consult with one of our health care experts today and learn more about the Gluta IV drip to experience its promising results
California Law and Professional Medical Board Liability Operating a wellness practice or medical spa in California introduces aggressive state-level enforcement layers that compound federal risk
During 1,036,587 person-years of follow-up, cholangiocarcinoma occurred among 92 patients with use of GLP-1-receptor agonists (incidence rate, 26 per 100,000 patient-years) and among 157 patients with use of sulfonylureas (incidence rate, 23 per 100,000 patient-years)
Most GLP-1 agents require gradual dose escalation to minimize gastrointestinal side effects, meaning patients start at lower-than-maintenance titration doses and increase incrementally over 820 weeks depending on the specific medication